racemetirosine has been researched along with Carcinoma, Squamous Cell in 4 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "For the detection of primary esophageal cancer, (18)F-FAMT-PET exhibited a sensitivity of 76." | 1.36 | 18F-FAMT-PET is useful for the diagnosis of lymph node metastasis in operable esophageal squamous cell carcinoma. ( Endo, K; Fukuchi, M; Inose, T; Kato, H; Kuwano, H; Miyazaki, T; Nakajima, M; Oriuchi, N; Sakai, M; Sano, A; Sohda, M; Suzuki, S; Tanaka, N, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, M | 2 |
| Higuchi, T | 3 |
| Nakajima, T | 1 |
| Andriana, P | 1 |
| Hirasawa, H | 1 |
| Tokue, A | 1 |
| Kurihara, J | 1 |
| Yokoo, S | 2 |
| Tsushima, Y | 3 |
| Sohda, M | 2 |
| Honjyo, H | 1 |
| Hara, K | 1 |
| Ozawa, D | 1 |
| Suzuki, S | 2 |
| Tanaka, N | 2 |
| Sano, A | 2 |
| Sakai, M | 2 |
| Yokobori, T | 1 |
| Inose, T | 2 |
| Miyazaki, T | 2 |
| Ojima, H | 1 |
| Kuwano, H | 2 |
| Achmad, A | 1 |
| Arisaka, Y | 1 |
| Yokoo, H | 1 |
| Kato, H | 1 |
| Nakajima, M | 1 |
| Fukuchi, M | 1 |
| Oriuchi, N | 1 |
| Endo, K | 1 |
4 other studies available for racemetirosine and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Topics: alpha-Methyltyrosine; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Mouth Neoplasms; Pos | 2019 |
L-[3-18F]-α-methyltyrosine accumulation as a definitive chemoradiotherapy response predictor in patients with esophageal cancer.
Topics: Aged; Aged, 80 and over; alpha-Methyltyrosine; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophage | 2014 |
Effects of intratumoral inflammatory process on 18F-FDG uptake: pathologic and comparative study with 18F-fluoro-α-methyltyrosine PET/CT in oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; alpha-Methyltyrosine; Carcinoma, Squamous Cell; Female; Fluorodeoxyg | 2015 |
18F-FAMT-PET is useful for the diagnosis of lymph node metastasis in operable esophageal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; alpha-Methyltyrosine; Carcinoma, Squamous Cell; Esophageal Neoplasms | 2010 |